Balter Invenomic Market Risk Adjusted Performance

BIVRX Fund  USD 17.08  0.01  0.06%   
Balter Invenomic market-risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for Balter Invenomic Fund or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
  
Balter Invenomic Fund has current Market Risk Adjusted Performance of 1.05.

MRAP

 = 

ER[a] + (1/BETA - 1)

X

ER[a] - RFR)

 = 
1.05
ER[a] = Expected return on investing in Balter Invenomic
RFR = Risk Free Rate of return. Typically T-Bill Rate
BETA = Beta of the asset with market or selected benchmark.

Balter Invenomic Market Risk Adjusted Performance Peers Comparison

Balter Market Risk Adjusted Performance Relative To Other Indicators

Balter Invenomic Fund is third largest fund in market risk adjusted performance among similar funds. It is currently under evaluation in maximum drawdown among similar funds reporting about  2.62  of Maximum Drawdown per Market Risk Adjusted Performance. The ratio of Maximum Drawdown to Market Risk Adjusted Performance for Balter Invenomic Fund is roughly  2.62 
Compare Balter Invenomic to Peers

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas